Abstract:BACKGROUND:Decoy receptor 3 (DcR3) has been reported to be involved in different cancers. However, few related researches have been accomplished on the role of DcR3 in lung cancer.OBJECTIVE:To explore the expression level and clinicopathological implication of DcR3 protein in lung cancer tissues.MATERIALS AND METHODS:Immunohistochemistry was used to examine DcR3 protein expression in lung cancer (n=365) and normal lung tissues (n=26). The relationships between DcR3 expression and clinical parameters were further investigated. Furthermore, the diagnostic and clinicopathological value of DcR3 mRNA was analyzed based on The Cancer Genome Atlas database in lung cancer patients.RESULTS:Compared to normal lung tissues, DcR3 expression was significantly higher in lung cancer (P=0.007) tissues, including small-cell lung cancer (P=0.001) and non-small-cell lung cancer (P=0.008). In addition, DcR3 expression was related to tumor-node-metastasis (TNM) stage (P<0.001), tumor diameter (P=0.007), distant metastasis (P<0.001), and lymph node metastasis (P<0.001) in lung cancers. When concerning non-small-cell lung cancer, consistent correlations between DcR3 expression and TNM stage (P<0.001), tumor diameter (P=0.019), distant metastasis (P<0.001), and lymph node metastasis (P<0.001) were found. Simultaneously, in small-cell lung cancer, TNM stage (P=0.004) and lymph node metastasis (P=0.005) were also associated with DcR3 expression. Additionally, receiver operator characteristic curve revealed that the area under curve (AUC) of DcR3 was 0.637 (95% confidence interval [CI] 0.531-0.742) for lung cancer. Furthermore, DcR3 was overexpressed in both adenocarcinoma and squamous cell carcinoma tissues than in noncancerous lung tissues (all P<0.0001) based on the data from The Cancer Genome Atlas. AUC of DcR3 was 0.726 (95% CI 0.644-0.788) for lung adenocarcinoma patients and 0.647 (95% CI 0.566-0.728) for squamous cell carcinoma patients. DcR3 expression was also related to the overall survival (P<0.001) and disease-free survival (P<0.001) of lung adenocarcinoma according to the data from The Cancer Genome Atlas.CONCLUSION:Our study confirms that DcR3 might be involved in the tumorigenesis and deterioration of lung cancer. Therefore, the detection of DcR3 gains the potential to be applied in the clinic for screening and progression prediction of lung cancer.

Expressions of DcR3 and caspase-3 and their significance in colorectal adenocarcinoma and precancerous lesions

[Expression of Caspase Apoptosis Pathway Genes Mrna in Colorectal Cancer and Polyps].

Expressions and significance of PARP-1 and caspase-3 in colorectal neoplasms

Expression and Clinicopathological Implication of DcR3 in Lung Cancer Tissues: a Tissue Microarray Study with 365 Cases.

Association of selected polymorphisms of CCND1, p21, and caspase8 with colorectal cancer risk.

Expression of Survivin and Its Correlation with Expression of Bcl-2 and P53 in Colorectal Adenocarcinoma

Overexpression and Clinicopathological Contribution of DcR3 in Bladder Urothelial Carcinoma Tissues

Over-expression of decoy receptor 3 in gastric precancerous lesions and carcinoma.

Clinical Significance of eIF4E and CyclinD1 Expression in Primary Colorectal Cancer

Decoy Receptor 3 Expression in Esophageal Squamous Cell Carcinoma: Correlation with Tumour Invasion and Metastasis

Diagnostic Potential Of Serum Exosomal Colorectal Neoplasia Differentially Expressed Long Non-Coding Rna (Crnde-P) And Microrna-217 Expression In Colorectal Carcinoma

MicroRNA-421 Inhibits Apoptosis by Downregulating Caspase-3 in Human Colorectal Cancer

Expression and CD147,MMP-9 and P-Erk in Invasive Ductal Carcinoma of Breast and Its Significance

Expression and significance of Her-2,P53 and Ki-67 in colorectal cancer

Expression of RhoA and RhoC in Colorectal Carcinoma and Its Relations with Clinicopathological Parameters.

Overexpression of Decoy Receptor 3 in Hepatocellular Carcinoma and Its Association with Resistance to Fas Ligand-Mediated Apoptosis

Clinicopathological significance of CBX3 in colorectal cancer: An intensive expression study based on formalin-fixed and paraffin-embedded tissues

The Suppressing Effects of Dkk3 Expression on Aggressiveness and Tumorigenesis of Colorectal Cancer

Caspase-3 over-expression is associated with poor overall survival and clinicopathological parameters in breast cancer: a meta-analysis of 3091 cases.

Expression of death decoy receptor-3 (DcR3) in human breast cancer and its functional effects on breast cancer cells in vitro.

Correlation Between DCAMKL-1 Protein Expression and K-ras Gene Mutation in Colorectal Cancer